Ono Pharmaceutical Co (MEX:4528N) Shares Outstanding (EOP): 470 Mil (As of Mar. 2026)


MEX:4528N Ono Pharmaceutical Co Ltd MEX:4528N
88 GF Score
Price MXN341.69
GF Value MXN324.16
! 2 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Shares Outstanding (EOP)?

Ono Pharmaceutical Co MEX:4528N 88 Shares Outstanding (EOP) is 470 Mil as of Mar. 2026. GuruFocus rates MEX:4528N with a GF Score™ of 88/100 and a GF Value™ of MXN324.16. The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Ono Pharmaceutical Co's shares outstanding for the quarter that ended in Mar. 2026 was 470 Mil.

Ono Pharmaceutical Co's quarterly shares outstanding declined from Dec. 2025 (470 Mil) to Mar. 2026 (470 Mil). It means Ono Pharmaceutical Co bought back shares from Dec. 2025 to Mar. 2026 .

Ono Pharmaceutical Co's annual shares outstanding increased from Mar. 2025 (470 Mil) to Mar. 2026 (470 Mil). It means Ono Pharmaceutical Co issued new shares from Mar. 2025 to Mar. 2026 .


Ono Pharmaceutical Co  (MEX:4528N) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Ono Pharmaceutical Co Shares Outstanding (EOP) Related Terms


Ono Pharmaceutical Co Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co Shares Outstanding (EOP) Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 488.25 488.33 469.65 469.77 469.91

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 469.77 469.77 469.91 469.91 469.91

MEX:4528N vs LLY, JNJ, ABBV: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ono Pharmaceutical Co Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Ono Pharmaceutical Co's Shares Outstanding (EOP) falls into.


MEX:4528N
88GF Score
Ono Pharmaceutical Co Ltd MEX:4528N
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 470 Mil mean?
Ono Pharmaceutical Co (MEX:4528N) has a Shares Outstanding (EOP) of 470 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Ono Pharmaceutical Co and its competitors.
Is Ono Pharmaceutical Co's Shares Outstanding (EOP) too high?
Ono Pharmaceutical Co's current Shares Outstanding (EOP) is 470 Mil. Overall, Ono Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Shares Outstanding (EOP) compare to LLY and JNJ?
Ono Pharmaceutical Co's Shares Outstanding (EOP) of 470 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Ono Pharmaceutical Co and its competitors. Ono Pharmaceutical Co's current Shares Outstanding (EOP) is 470 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Ono Pharmaceutical Co (MEX:4528N) has a current Shares Outstanding (EOP) of 470 Mil. The stock's GF Value™ is MXN324.16, compared to a current price of MXN341.69 — trading 5.4% above its estimated fair value. The current Shares Outstanding (EOP) is 470 Mil. Ono Pharmaceutical Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Ono Pharmaceutical Co (MEX:4528N), the current Shares Outstanding (EOP) is 470 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (MEX:4528N) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN341.69 is trading 5.4% above its estimated GF Value™ of MXN324.16.

Key valuation signals for MEX:4528N:

  • Shares Outstanding (EOP): 470 Mil
  • GF Value™: MXN324.16 vs. price of MXN341.69 (5.4% above fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEX:4528N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
88GF Score

Get the complete analysis for MEX:4528N

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN341.69
Price
MXN324.16
GF Value